TRPA1 as a drug target—promise and challengesJun Chen, David H. Hackos|Naunyn-Schmiedeberg s Archives of Pharmacology|2015Cited by 156
GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease ModelsJesse E. Hanson, Jorge J. Palop, Justin Elstrott et al.|Cell Reports|2020Cited by 91